Evidence map›Paper›PMID 38069141›Full record

ArticleInternational journal of molecular sciences2023

Melatonin Ameliorates Neuropsychiatric Behaviors, Gut Microbiome, and Microbiota-Derived Metabolites in Rats with Chronic Sleep Deprivation.

Bingcong Li, Yin-Ru Hsieh, Wen-De Lai, Te-Hsuan Tung, Yu-Xuan Chen, Chia-Hui Yang, Yu-Chiao Fang, Shih-Yi Huang

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Special Issue "Depression: From Molecular Basis to Therapy".International journal of molecular sciences · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Bingcong LiSchool of Nutrition and Health Sciences, Taipei Medical University, Taipei 110301, Taiwan.ORCID 0009-0007-1245-8907
Yin-Ru HsiehSchool of Nutrition and Health Sciences, Taipei Medical University, Taipei 110301, Taiwan.
Wen-De LaiSchool of Nutrition and Health Sciences, Taipei Medical University, Taipei 110301, Taiwan.
Te-Hsuan TungSchool of Nutrition and Health Sciences, Taipei Medical University, Taipei 110301, Taiwan.ORCID 0000-0002-0712-4861
Yu-Xuan ChenSchool of Nutrition and Health Sciences, Taipei Medical University, Taipei 110301, Taiwan.
Chia-Hui YangSchool of Nutrition and Health Sciences, Taipei Medical University, Taipei 110301, Taiwan.
Yu-Chiao FangSchool of Nutrition and Health Sciences, Taipei Medical University, Taipei 110301, Taiwan.
Shih-Yi HuangSchool of Nutrition and Health Sciences, Taipei Medical University, Taipei 110301, Taiwan.ORCID 0000-0003-2914-5513
Taipei Medical University · TWTaipei Medical University Hospital · TW

Funding

National Science and Technology Council MOST110-2314-B-038-154, 110-2320-B-039-047-MY3, NSTC 111-2813-C-038-090-B, 111-2813-C-038-092-B
6 · The paper itself

Abstract

With the increasing prevalence of sleep deprivation (SD)-related disorders, the effective treatment of sleep disorders has become a critical health research topic. Thus, we hypothesized and investigated the effectiveness of a 3-week melatonin intervention on neuropsychiatric behavioral responses mediated throughout melatonin receptors, gut microbiota, and lipid metabolites in rats with chronic SD. Eighteen 6-week-old Wistar rats were used and divided into the control grup (C, n = 6), SD group (n = 6), and melatonin-supplemented group (SDM, n = 6). During weeks 0 to 6, animals were provided with the AIN-93M diet and free access to water. Four-week chronic SD was conducted from weeks 7 to 10. Exogenous melatonin administration (10 mg/kg BW) was injected intraperitoneally 1 h before the daily administration of SD for 3 weeks in the SDM group. SD rats exhibited anxiety-like behavior, depression-like behavior, and cognitive impairment. Exogenous melatonin administration ameliorated neuropsychiatric behaviors induced by chronic SD. Analysis of fecal metabolites indicated that melatonin may influence brain messaging through the microbiota-gut-brain axis by increasing the production of short-chain fatty acids (SCFA) and decreasing the production of secondary bile acids (SBA). Four-week SD reduced the cerebral cortex expression of MT1, but not in the colon. Chronic SD led to anxiety and depression-like behaviors and cognitive decline, as well as the reduced intestinal level of SCFAs and the enhanced intestinal level of SBAs in rats. In this work, we confirmed our hypothesis that a 3-week melatonin intervention on neuropsychiatric behavioral response mediated throughout melatonin receptors, gut microbiota, and lipid metabolites in rats with chronic SD.

Indexed as

Gastrointestinal MicrobiomeMelatoninMicrobiotaAnimalsFatty Acids, VolatileRatsRats, WistarReceptors, MelatoninSleep DeprivationFatty Acids, VolatileMelatoninReceptors, Melatonincognitivedepression-like behaviorintestinal metabolitesmelatoninsleep deprivation

Identifiers

PMID38069141
PMCPMC10706682
OpenAlexW4389048177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.